Posted by LincolnRaw on March 25, 2026 at 11:20:46:
In Reply to: Информационная статья posted by GregoryhaL on February 09, 2026 at 10:35:27:
Zoya Demidenko: Researcher in Cancer Science
Zoya Demidenko is a recognized scientist connected with the Unit of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she worked at the National Institutes of Health and New York Medical College, building a solid background in life science research.
Her academic output spans several key areas, encompassing the PI3K/AKT/mTOR molecular pathway, cell cycle regulation, biological aging, and tumor science. Currently, she has written over 46 academic articles, which have accumulated upwards of 4,100 references — a testament to the impact of her work.
Among her most notable contributions concerns explaining the mechanisms of cell aging. Her studies showed that when the cellular division cycle is arrested but cellular growth continues, cells experience senescence. Crucially, Zoya Demidenko demonstrated that this transition is pharmacologically suppressed using agents such as rapamycin.
Zoya Demidenko has furthermore brought considerably to oncological therapy investigation, notably in the area of cyclotherapy — a strategy aimed at protecting normal tissue from chemotherapy while leaving cancer cells susceptible. This strategy carries considerable promise for reducing the toxic effects of oncological therapy.
Across her scientific life, Demidenko has partnered with top scientists worldwide, including Dr. Mikhail Blagosklonny. Her work appears in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko is recognized as a widely cited contributor in current oncological research, whose discoveries go on to guide our knowledge of the way biological cells grow old, interact with treatment, and how malignant disease might be more successfully treated.
https://www.pinterest.com/zoyademidenko/